🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
817.00
-4.50 (-0.55%)
At close: Nov 20, 2026

NATCO Pharma Revenue

NATCO Pharma had revenue of 9.67B INR in the quarter ending September 30, 2026, a decrease of -29.03%. This brings the company's total for the last twelve months to 30.92B, down -29.56% year-over-year. In the fiscal year ending March 31, 2026, NATCO Pharma had annual revenue of 40.82B, down -7.90%.

Revenue (ttm)
30.92B
Revenue Growth
-29.56%
P/S Ratio
5.17
Revenue / Employee
6.98M
Employees
4,433
Market Cap
159.74B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Pharmaceuticals 39.40B 96.6%
  • Agro Chemicals 1.38B 3.4%

By Geography

Chart
  • United States of America (USA) 23.81B 58.4%
  • Rest of The World 10.06B 24.7%
  • India 6.91B 16.9%
Fiscal year ended Mar 31, 2026 See the full NATCO Pharma breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202640.82B-3.50B-7.90%
Mar 31, 202544.32B4.30B10.74%
Mar 31, 202440.02B12.94B47.76%
Mar 31, 202327.09B7.62B39.17%
Mar 31, 202219.46B-1.10B-5.35%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

NATCO Pharma News

More News